ChoA Pharmaceutical Co., LTD.

KOSDAQ:A034940 Stock Report

Market Cap: ₩32.4b

ChoA Pharmaceutical Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Sung-Hwan Cho

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership6.1%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Some ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940) Shareholders Look For Exit As Shares Take 31% Pounding

Dec 09
Some ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940) Shareholders Look For Exit As Shares Take 31% Pounding

ChoA Pharmaceutical (KOSDAQ:034940) Is Carrying A Fair Bit Of Debt

Nov 12
ChoA Pharmaceutical (KOSDAQ:034940) Is Carrying A Fair Bit Of Debt

Would ChoA Pharmaceutical (KOSDAQ:034940) Be Better Off With Less Debt?

Aug 12
Would ChoA Pharmaceutical (KOSDAQ:034940) Be Better Off With Less Debt?

ChoA PharmaceuticalLtd (KOSDAQ:034940) Has A Pretty Healthy Balance Sheet

Jan 31
ChoA PharmaceuticalLtd (KOSDAQ:034940) Has A Pretty Healthy Balance Sheet

Did You Miss ChoA PharmaceuticalLtd's (KOSDAQ:034940) 36% Share Price Gain?

Dec 09
Did You Miss ChoA PharmaceuticalLtd's (KOSDAQ:034940) 36% Share Price Gain?

CEO

Sung-Hwan Cho (54 yo)

no data

Tenure

Mr. Cho Sung-Hwan serves as Managing Director of Kwang Myung Electric Engineering Co. Ltd. Mr. Sung-Hwan serves as the Chief Executive Officer of ChoA Pharmaceutical Co. Ltd. and Medipharm Co., Ltd.Mr. Su...

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 02:24
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ChoA Pharmaceutical Co., LTD. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution